hGDH1: Key Regulator of Hemoglobin and Cellular Signaling (G2746)

Target Name: GLUD1

NCBI ID: G2746

GLUD1

hGDH1: Key Regulator of Hemoglobin and Cellular Signaling

GLUD1 (hGDH1) is a gene that encodes for the heme biosynthesis protein hGDH1. Heme biosynthesis is a critical process in the production of hemoglobin (HB), which is a protein found in red blood cells that is responsible for carrying oxygen from the lungs to the rest of the body. When oxygen levels in the body are low, the hGDH1 gene is activated, leading to the production of more heme proteins, including hGB.

hGDH1 is a key regulator of heme biosynthesis and its levels are closely monitored by the body. When hGDH1 levels are too low, the production of hGB is limited, leading to anemia. On the other hand, when hGDH1 levels are too high, the Production of hGB is increased, leading to hyperkalemia (elevated potassium levels in the blood).

One of the unique features of hGDH1 is its ability to self-regulate its levels. This is accomplished through a process called negative feedback, in which the concentration of hGDH1 in the blood reacts to its own level. If the concentration of hGDH1 in the blood is too high, it will bind to a protein called HDAC, which is itself a protein that binds to hGDH1. This will prevent the further production of hGDH1, leading to a decrease in the concentration of hGDH1 in the blood.

Another mechanism by which hGDH1 is regulated is through its role in the production of fetal hemoglobin. During fetal development, hGDH1 is expressed in the placenta and the fetal blood vessels, where it is involved in the production of hGB. The levels of hGDH1 in the Fetal blood vessels are closely monitored by the body and are critical for the proper development of the fetal blood system.

In addition to its role in heme biosynthesis, hGDH1 has also been shown to have a number of potential drug targets. For example, hGDH1 has been shown to be involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including aging, neurodegenerative diseases, and cancer.

In addition, hGDH1 has also been shown to be involved in the regulation of cellular signaling pathways. For example, hGDH1 has been shown to be involved in the production of autophagy, a process by which cells break down and recycle their own damaged or unnecessary components . This is important for maintaining cellular health and has been implicated in a number of diseases, including cancer.

Furthermore, hGDH1 has also been shown to be involved in the regulation of inflammation. For example, hGDH1 has been shown to be involved in the production of pro-inflammatory cytokines, which contribute to the development of inflammatory diseases. This is important for understanding the mechanisms of inflammation and for the development of new treatments for inflammatory diseases.

In conclusion, GLUD1 (hGDH1) is a gene that plays a critical role in the production of hemoglobin and the regulation of heme biosynthesis. Its levels are closely monitored by the body and its role in the production of fetal hemoglobin and the regulation of cellular signaling pathways, as well as its involvement in the regulation of inflammation makes it an attractive drug target. Further research is needed to fully understand the mechanisms of hGDH1 and its potential as a drug.

Protein Name: Glutamate Dehydrogenase 1

Functions: Mitochondrial glutamate dehydrogenase that catalyzes the conversion of L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle (PubMed:11032875, PubMed:16959573, PubMed:11254391, PubMed:16023112). Plays a role in insulin homeostasis (PubMed:9571255, PubMed:11297618). May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate (By similarity)

The "GLUD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLUD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets